Find uplifting stories about heroes, innovations, and solutions
36 results for "obesity treatment"
Scientists have found a naturally occurring molecule that works like Ozempic but without the nausea, constipation, or muscle loss. The breakthrough came from an AI tool that scanned thousands of potential peptides hiding in human genes.
Millions of Americans now have a new option for weight management that doesn't require needles or strict meal planning. The FDA just approved Foundayo, a once-daily pill that can be taken anytime with or without food.
Scientists discovered that two genes can help predict who will lose weight on popular obesity medications and who might experience side effects. The breakthrough could personalize treatment for millions seeking help with weight loss.
Millions of Americans struggling with obesity now have a new option: the FDA just approved Foundayo, the first oral tablet in a groundbreaking class of weight-loss medications. This pill could transform treatment by offering an easier alternative to weekly injections.
Your brain's fullness signal doesn't come from neurons alone. Researchers discovered that support cells called astrocytes play a starring role in telling you when to stop eating.
The FDA just approved a new obesity pill that's easier to take than any competitor, and it hit pharmacy shelves in record-breaking time. Patients now have more options than ever to manage their weight without needles. #
The FDA just approved a convenient new weight-loss pill that works without food restrictions and could cost as little as $25 monthly with insurance. Over 3,000 people in trials lost an average of 25 pounds, and the drug starts shipping Monday.
A new weight-loss pill that can be taken any time of day just won FDA approval, making treatment easier for millions of Americans. The once-daily tablet offers a needle-free alternative starting at $149 monthly.
Millions seeking weight loss solutions can now access a daily pill instead of weekly injections. The FDA approved Eli Lilly's Foundayo, making treatment easier and more accessible for people nationwide.
Researchers discovered how a protein called SLIT3 splits in two to build the blood vessels and nerves that help brown fat burn calories instead of storing them. The breakthrough could lead to obesity treatments that boost energy burning rather than just cutting appetite.
Researchers discovered how a protein called SLIT3 helps brown fat build the blood vessels and nerves it needs to burn calories instead of storing them. This breakthrough could lead to new obesity treatments that boost metabolism rather than just reducing appetite.
Researchers discovered how a protein called SLIT3 helps brown fat build the blood vessels and nerves it needs to burn calories effectively. This breakthrough could lead to obesity treatments that increase energy burning instead of just reducing appetite.
Scientists studying how pythons survive on one massive meal per year discovered a natural molecule that helped obese mice lose 9% of their body weight. The finding could one day lead to new obesity treatments inspired by nature's most extreme eaters.
India is launching affordable generic versions of popular weight-loss drugs after a key patent expired, potentially helping millions worldwide access treatments that once cost hundreds of dollars monthly. Prices could drop from $236 to just $60 per month.
A new, more powerful version of Wegovy just got FDA approval and could help people who haven't reached their weight loss goals with standard doses. The higher-dose shot helped study participants lose an extra 8 pounds on average.
A new, stronger version of the popular weight loss medication Wegovy just got FDA approval, giving more Americans access to potentially more effective obesity treatment. The approval came through a new fast-track program designed to speed up medicines that address major health priorities.
Starting this weekend, affordable generic versions of Ozempic and Wegovy will reach countries representing 40% of the world's population. Prices could eventually drop to $15 per month, making the life-changing medication accessible to millions who couldn't afford it before.
A daily pill helped patients lose 16% of their body weight in 44 weeks, outperforming other oral medications in development. The breakthrough could make obesity treatment more accessible to millions who avoid injections.
A new class of medications is transforming obesity treatment by working with the body's hunger signals rather than against them, helping patients lose up to 30% of their body weight. These GLP-1 drugs are proving that obesity has deep biological roots beyond willpower alone.
More people with obesity are getting treatment now than at any point in the past 20 years, thanks to breakthrough medications like semaglutide. A major study tracking over 200,000 patients shows how policy changes and new drugs transformed access to life-changing care.
Showing 20 of 36